A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy (Q33360952)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy |
scientific article |
Statements
1 reference
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy (English)
1 reference
Alan Sandler
1 reference
Michael Gordon
1 reference
Dinesh P De Alwis
1 reference
Isabelle Pouliquen
1 reference
Lisa Green
1 reference
Phil Marder
1 reference
Ajai Chaudhary
1 reference
Karen Fife
1 reference
Linda Battiato
1 reference
Christopher Sweeney
1 reference
Christopher Jordan
1 reference
Michael Burgess
1 reference
Christopher A Slapak
1 reference
1 reference
Identifiers
1 reference